Cancer Clinical Trials Division


The QCRI Cancer Clinical Trials division houses the Canadian Cancer Trials Group (CCTG).  CCTG is one of the national programs of the Canadian Cancer Society Research Institute (CCSRI), and is supported by the Canadian Cancer Society (CCS).

CCTG  is a cooperative oncology group which carries out clinical trials in cancer therapy, supportive care and prevention. Within Canada, over 80 institutions participate in the clinical trials run through the network. CCTG also provides the organizational mechanism for collaboration in international trials in the United States, Europe, Australia, New Zealand, Japan and Korea.

CCTG  has two main areas of study:

  1. investigational new drugs, providing a centralized focus of knowledge, expertise, and experience to help Canadian investigators compete successfully for access to promising and scientifically interesting new agents; and
  2. comparative randomized trials, developing and conducting randomized phase II and III trials evaluating innovative cancer treatments across the spectrum of adult malignancies.

Investigators at CCTG have played lead roles in the development of new methodology for study designs, assessment of response, and toxicity.

Cancer Clinical Trials/CCTG investigators at Queen’s University also play an important role in mentoring and supervising cancer graduate students and post-doctoral and clinical fellows in the areas of:

  • biobanking
  • clinical drug development
  • clinical trials in specific cancer settings
  • clinical trial methodologies/biostatistical theory

For more information about individual investigators please review the members’ pages.  For more information about the CCTG or QCRI Cancer Clinical Trials division, please contact:

Janet Dancey, MD, FRCP(C)
Director, Cancer Clinical Trials Division
Queen’s Cancer Research Institute
1st Floor, 10 Stuart Street
Kingston, ON  K7L 3N6 Canada

JDancey@ctg.queensu.ca

Phone: 613-533-6430